MONTU has confirmed it will again take part in the Kosi Challenge, with a team drawn from across Montu's clinical, operational and corporate functions - including chief executive officer Myles Lawlor - to climb Mount Kosciuszko, raising funds and awareness for Australians living with rare, less common and complex cancers.
Organised by Rare Cancers Australia, the Kosi Challenge, brings together patients, clinicians, researchers, industry and community members to climb the highest peak in Australia in solidarity with those affected.
Since its launch in 2013, it has raised millions of dollars to fund patient navigation, clinical trial access, advocacy and research for rare and less common cancers.
Lawlor said the company's participation in the Kosi Challenge demonstrated its commitment to patients whose needs sit outside traditional care pathways.
"I've met too many patients who feel like they're carrying their illness on their own - pushed between appointments, forms and systems that don't always see the whole person," he said.
"Climbing alongside our team and in support of people living with rare cancers is my way of saying: you're not alone, and you matter.
"Patient-centred care isn't just something we talk about at Montu - it's something we show up for, even when it's hard."
The event takes place on 13-14 Mar 2026, with climbs ranging from 13 to 21km.
Learn more about the Montu Mountaineers' fundraising efforts HERE. KB
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jan 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jan 26
